Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• Challenges for the FDA: The Future of Drug Safety, Workshop Summary (ISBN ) Leslie Pray and Sally Robinson, Rapporteurs, Forum on Drug Discovery, Development, and Translation


• Adverse Drug Event Reporting: The Roles of Consumers and Health-Care Professionals: Workshop Summary (ISBN ) Forum on Drug Discovery, Development, and Translation, Jeffrey M. Drazen, Jennifer Rainey, Heather Begg, and Adrienne Stith Butler, Rapporteurs


• Building a National Framework for the Establishment of Regulatory Science for Drug Development:Workshop Summary (ISBN ) Yeonwoo Lebovitz, Rebecca English, and Anne Claiborne; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development: Workshop Summary (ISBN ) Steve Olson and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Countering the Problem of Falsified and Substandard Drugs (ISBN ) Lawrence O. Gostin and Gillian J. Buckley, Editors; Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products; Board on Global Health; Institute of Medicine


• Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment (ISBN ) Committee on Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment, National Research Council


• Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease (ISBN ) Christine M. Micheel and John R. Ball, Editors; Committee on Qualifications of Biomarkers and Surrogate Endpoints in Chronic Disease; Institute of Medicine


• Cancer Biomarkers: The Promises and Challenges of Improving Detection and Treatment (ISBN ) Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment, Sharyl J. Nass and Harold L. Moses, Editors


• Perspectives on Biomarker and Surrogate Endpoint Evaluation:Discussion Forum Summary (ISBN ) Alison Mack, Erin Balogh, and Christine Micheel, Rapporteurs; Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease; Institute of Medicine


• Accelerating the Development of Biomarkers for Drug Safety:Workshop Summary (ISBN ) Steve Olson, Sally Robinson, and Robert Giffin, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Neuroscience Biomarkers and Biosignatures: Converging Technologies, Emerging Partnerships: Workshop Summary (ISBN ) Miriam Davis, Sarah Hanson, Bruce Altevogt, Rapporteurs, Forum on Neuroscience and Nervous System Disorders, Institute of Medicine


• Rare Diseases and Orphan Products: Accelerating Research and Development (ISBN ) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Accelerating Rare Diseases Research and Orphan Product Development; Institute of Medicine


• Scientific Standards for Studies on Modified Risk Tobacco Products (ISBN ) Committee on Scientific Standards for Studies on Modified Risk Tobacco Products; Institute of Medicine


• Toxicity Pathway-Based Risk Assessment:Preparing for Paradigm Change: A Symposium Summary (ISBN ) Ellen Mantus, Rapporteur; Standing Committee on Risk Analysis Issues and Reviews; National Research Council


• Genome-Based Therapeutics:Targeted Drug Discovery and Development: Workshop Summary (ISBN ) Adam C. Berger and Steve Olson, Rapporteurs; Roundtable on Translating Genomic-Based Research for Health; Board on Health Sciences Policy; Institute of Medicine


• Improving the Quality of Cancer Clinical Trials:Workshop Summary (ISBN ) Margie Patlak and Sharyl Nass, Rapporteurs


• Scientific Frontiers in Developmental Toxicology and Risk Assessment (ISBN ) Committee on Developmental Toxicology, Board on Environmental Studies and Toxicology, National Research Council


• Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary (ISBN ) Diana E. Pankevich, Miriam Davis, and Bruce M. Altevogt, Rapporteurs; Forum on Neuroscience and Nervous System Disorders; Institute of Medicine


• A National Cancer Clinical Trials System for the 21st Century:Reinvigorating the NCI Cooperative Group Program (ISBN ) Sharyl J. Nass, Harold L. Moses, and John Mendelsohn, Editors; Committee on Cancer Clinical Trials and the NCI Cooperative Group Program; Institute of Medicine


• Human Biomonitoring for Environmental Chemicals (ISBN ) Committee on Human Biomonitoring for Environmental Toxicants, National Research Council


• Facilitating Collaborations to Develop Combination Investigational Cancer Therapies: Workshop Summary (ISBN ) Margie Patlak, Erin Balogh, and Sharyl J. Nass, Rapporteurs; National Cancer Policy Forum; Institute of Medicine


• Validation of Toxicogenomic Technologies: A Workshop Summary (ISBN ) Committee on Validation of Toxicogenomic Technologies: A Focus on Chemical Classification Strategies, Committee on Emerging Issues and Data on Environmental Contaminants, National Research Council


• Rational Therapeutics for Infants and Children:Workshop Summary (ISBN ) Sumner Yaffe, M.D., Editor; Ronald W. Estabrook, Peter Bouxsein, Sarah Pitluck, Jonathan R. Davis, Roundtable on Research and Development of Drugs, Biologics, and Medical Devices, Division of Health Sciences Policy


• Toxicity Testing in the 21st Century: A Vision and a Strategy (ISBN ) Committee on Toxicity Testing and Assessment of Environmental Agents, National Research Council


• Advancing Regulatory Science for Medical Countermeasure Development: Workshop Summary (ISBN ) Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Forum on Medical and Public Health Preparedness for Catastrophic Events; Institute of Medicine


• Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction (ISBN ) Kathleen Stratton, Padma Shetty, Robert Wallace, and Stuart Bondurant, Editors, Committee to Assess the Science Base for Tobacco Harm Reduction, Board on Health Promotion and Disease Prevention


• Addressing the Threat of Drug-Resistant Tuberculosis:A Realistic Assessment of the Challenge: Workshop Summary (ISBN ) Robert Giffin and Sally Robinson, Rapporteurs; Institute of Medicine


• Evolution of Translational Omics: Lessons Learned and the Path Forward (ISBN ) Christine M. Micheel, Sharly J. Nass, and Gilbert S. Omenn, Editors; Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials; Board on Health Care Services; Board on Health Sciences Policy; Institute of Medicine


• Federal Agency Roles in Cancer Drug Development from Preclinical Research to New Drug Approval: The National Cancer Institute and the Food and Drug Administration (ISBN )


• Genes, Behavior, and the Social Environment: Moving Beyond the Nature/Nurture Debate (ISBN ) Committee on Assessing Interactions Among Social, Behavioral, and Genetic Factors in Health, Lyla M. Hernandez and Dan G. Blazer, Editors


• Ethical and Scientific Issues in Studying the Safety of Approved Drugs (ISBN ) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs; Institute of Medicine


• Extending the Spectrum of Precompetitive Collaboration in Oncology Research:Workshop Summary (ISBN ) Margie Patlak, Sharyl J. Nass, and Erin Balogh, Rapporteurs; Institute of Medicine


• Safety of Genetically Engineered Foods: Approaches to Assessing Unintended Health Effects (ISBN ) Committee on Identifying and Assessing Unintended Effects of Genetically Engineered Foods on Human Health, National Research Council


• Saving Women's Lives: Strategies for Improving Breast Cancer Detection and Diagnosis (ISBN ) Janet E. Joy, Edward E. Penhoet, and Diana B. Petitti, Editors, Committee on New Approaches to Early Detection and Diagnosis of Breast Cancer, Institute of Medicine and National Research Council


• Application of Toxicogenomics to Cross-Species Extrapolation:A Report of a Workshop (ISBN ) Committee on Applications of Toxicogenomics to Cross-Species Extrapolation, Committee on Emerging Issues and Data on Environmental Contaminants, National Research Council


• Interactions of Drugs, Biologics, and Chemicals in U.S. Military Forces (ISBN ) Robert G. Petersdorf, William F. Page, and Susan Thaul, Editors, Committee to Study the Interactions of Drugs, Biologics, and Chemicals in U.S. Military Forces


• The Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa: Global and Local Challenges and Solutions: Workshop Summary (ISBN ) Steve Olson, Yeonwoo Lebovitz, and Anne Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine; Academy of Science of South Africa


• Live Variola Virus:Considerations for Continuing Research (ISBN ) Ann M. Arvin and Deepali M. Patel, Editors; Committee on the Assessment of Future Scientific Needs for Live Variola Virus; Institute of Medicine


• Policy Issues in the Development of Personalized Medicine in Oncology:Workshop Summary (ISBN ) Margie Patlak and Laura Levit, Rapporteurs; Institute of Medicine


• Toxicity Testing for Assessment of Environmental Agents: Interim Report (ISBN ) Committee on Toxicity Testing and Assessment of Environmental Agents, National Research Council


• Biomarkers:Medical and Workplace Applications (ISBN ) by Mortimer L. Mendelsohn, Lawrence C. Mohr, and John P. Peeters, Editors


• The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop (ISBN ) Steve Olson, Rebecca English, and Anne Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine; Russian Academy of Medical Sciences


• Malaria: Obstacles and Opportunities (ISBN ) Stanley C. Oaks, Jr., Violaine S. Mitchell, Greg W. Pearson, and Charles C.J. Carpenter, Editors; Committee for the Study on Malaria Prevention and Control, Division of International Health


• Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment: The State of the Science, Evaluation, Implementation, and Economics ? Workshop Summary (ISBN ) Margie Patlak and Sharyl Nass, Rapporteurs


• Opportunities for Environmental Applications of Marine Biotechnology: Proceedings of the October 5-6, 1999, Workshop (ISBN ) Board on Biology, Oceans Studies Board, National Research Council


• Biosocial Surveys (ISBN ) Committee on Advances in Collecting and Utilizing Biological Indicators and Genetic Information in Social Science Surveys, Maxine Weinstein, James W. Vaupel, and Kenneth W. Wachter, Editors, National Research Council


• Opportunities in Biotechnology for Future Army Applications (ISBN ) Committee on Opportunities in Biotechnology for Future Army Applications, Board on Army Science and Technology, National Research Council


• Toxicogenomic Technologies and Risk Assessment of Environmental Carcinogens: A Workshop Summary (ISBN ) Committee on How Toxicogenomics Could Inform Critical Issues in Carcinogenic Risk Assessment of Environmental Chemicals, Committee on Emerging Issues and Data on Environmental Contaminants, National Research Council